🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Isabel Fabregat IDIBELL Asociación Española Contra el Cáncer RamonReyes Marisol Soengas Xose R Bustelo Asociación Española Contra el Cáncer Zaragoza Rafael Lopez ArkaitzCarracedoLAB Psancholab Ana Cuenda GMB-lab MD Anderson Cancer Center Madrid Hospiten Dr Ana Janic GomisLab @JorgeBarbazan Thanks to🥇Bristol Myers Squibb España & Portugal🥈MSD España AstraZeneca España J&J Innovative Medicine España @LillyES🥉Novartis España A.A.Matarrayos BonsaiLab   Agilent Technologies Integrated DNA Technologies JanvierLabs Pfizer España Recordati Rare Diseases España IIS Aragón STOmics MGI Thermo Fisher CeGaT GmbH ARAID HaploX Global Palex España

📍El 3rd #ASEICAMed Retreat reúne a 50 investigadores clínicos, líderes en oncología. 👉Clinician scientists as cornerstones in drug development ⏩Speakers de lujo: Antoni Ribas UCLA Health Johann S. De Bono The ICR 🪑: Joaquin Mateo Vall d’Hebron Institute of Oncology (VHIO) Valentina Gambardella INCLIVA

📢ASEICA Science Week: éxito de asistencia ✅Jornada ASEICA-Asociación Española Contra el Cáncer Zaragoza:1⃣0⃣0⃣ asistentes ✅#ASEICAJoven-Fundación Ibercaja Retreat:2⃣0⃣0⃣ jóvenes científic@s ✅19th #ASEICACongress:4⃣0⃣0⃣asistentes ✅3rd #ASEICAMed Retreat:5⃣0⃣oncólog@s ✅Taller #CONÓCELAS:1⃣5⃣ investigadoras

🚨Happy to share the results of BRCAN study 🚨: 🧬HER2-negative early breast cancer cohort (gBRCAm vs gBRCAwt) & neo/adjuvant anthracyclines ⚡️Significant reduction in LVEF in gBRCA1/2 patients compared to gBRCA1/2wt. ⚡️No differences in other biomarkers or QoL.

It was my pleasure meeting Dr. Ainhoa Madariaga a medial oncologist from Madrid here in Kuwait and looking forward to see her again Ainhoa Madariaga #female_oncologists

🎄✨ Wishing you all a season filled with joy, love, and warmth!🎁❄️ May your holidays be merry and bright, and the new year bring endless possibilities. #HappyHolidays #IJGConline #IJGCfamily Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO

Excited to share my doctoral thesis on luminal metastatic breast cancer treated with CDK4/6i, now published in European Journal of Cancer. Thanks to Eva M Ciruelos & Aleix Prat #PrecisionOncology for their invaluable support as well as SOLTI #cancerresearch #BreastCancer ejcancer.com/article/S0959-…

Rethinking control arms in platinum-resistant/refractory ovarian cancer - Ainhoa Madariaga oncodaily.com/science/ainhoa… #OvarianCancer #Cancer #OncoDaily #MedEd #MedX #MedNews #Medicine #Oncology #MedOnc

🚨The #2025SpecialIssue is HERE!🚨 📢 This March, we’re diving deep into the controversies in managing rare #GynecologicalCancers Enjoy 🆓 access all month! Don’t miss out—read, share, and join the conversation! 🔗 bit.ly/43DMppN Pedro T Ramirez Arthur_HC_Hsu

Ha sido un placer participar en el XIX curso SEOM para residentes hablando de pacientes mayores y frágiles. Es fantástico que desde R1 los oncólogos tengan formación en oncogeriatría 😍 #mirSEOM25

💟 Imagine a gender equal world 💟 A world free of bias, stereotypes, and discrimination 💟 A world that's diverse, equitable, and inclusive 💟 A world where difference is valued and celebrated Together we can forge #genderequality! Happy International Women's Day! #IWD2025

Using premalignant STIC lesions, our team at Princess Margaret Cancer Centre reveal how tumors exploit repetitive elements to induce immune tolerance. Could targeting viral mimicry conditioning enhance immunotherapy?

Magnífico elenco el de los #PremiosAtrevidos 2025. Han compartido velada con nuestros alumnos @aliagajosebello, El Panóptico de Jose Antonio Marina, Ainhoa Madariaga, COCO DÁVEZ y Seba Ulivi. Todos ellos se quedan en nuestro ❤️. #IESSapereAude #VillanuevadelPardillo #LiterariosAtrevimientos

Termina el Post SGO/ESGO 2025, con la SESIÓN IV, dedicada al cáncer de ovario. 🔍 La Dra. Ainhoa Madariaga ha expuesto los avances más recientes en tratamiento sistémico. 👥 El panel de discusión ha estado formado por la Dra. Yolanda García y el Dr. Fernando Gálvez, bajo la

Thanks for sharing our paper! This was a major effort and a pan-tumor-group initiative of the EORTC Young and Early Career Investigator network👨‍💼 We evaluated the integration of PROMs in routine cancer care. Findings in the article below⤵️ Great to have this in print at EJC!

🔥Just out in Nature Cancer! ✅ TAV16, our tumor-agnostic WES-based assay, ranks among the best for MRD detection. ✅ Immune evasion as the main driver progression in MSS CRC, opening new avenues for ICIs. 🙏SEOM Grupo Español de Tratamiento de Tumores Digestivos Instituto de Salud Carlos III (ISCIII) Hospital Clínic de València nature.com/articles/s4301…

Vulvar & vaginal cancers are rare but serious, with high recurrence & few systemic options. Surgery is standard; chemoradiation for advanced cases. Read this new #OpenAcces review by Glauco Baiocchi Brian Slomovitz, MD, MS, FACOG Angelica Nogueira Rodrigues et al: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… OncoAlert #gyncsm

New insights on SBRT in recurrent ovarian cancer – now in CTRO: “SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic review” 👉 doi.org/10.1016/j.ctro… 🎯 Local control ⏳ Delayed systemic therapy ⚖️ Personalized strategy EORTC